Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer-Reference-Cited by-同舟云学术

Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer

Published:2022-04-11 Issue:7 Volume:60 Page:e159-e160
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Ames Erik¹,Bowen Raffick A.R.¹

Affiliation:

1. Department of Pathology , Stanford University , Stanford , CA , USA

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2022-0204/pdf

Reference6 articles.

1. Bargnoux, AS, Sutra, T, Badiou, S, Kuster, N, Dupuy, AM, Mourad, G, et al.. Evaluation of the new Siemens tacrolimus assay on the dimension EXL integrated chemistry system analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method. Ther Drug Monit 2016;38:808–12. https://doi.org/10.1097/ftd.0000000000000331.

2. Kalt, DA. Tacrolimus: a review of laboratory detection methods and indications for use. Lab Med 2017;48:e62–e65. https://doi.org/10.1093/labmed/lmx056.

3. Clinical and Laboratory Standards Institute (CLSI). Preparation and testing of reagent water in the clinical laboratory; approved guideline. 4th ed. CLSI document GP40-A4-AMD. Clinical and Laboratory Standards Institute, Wayne, PA, 2012.

4. Nabulsi, R, Al-Abbadi, MA. Review of the impact of water quality on reliable laboratory testing and correlation with purification techniques. Lab Med 2014;45:e159–65. https://doi.org/10.1309/lmlxnd0wnrjj6u7x.

5. U.S. Food and Drug Administration. Q2(R1) Validation of Analytical Procedures: Text and Methodology Guidance for Industry. Available from: https://www.fda.gov/media/152208/download [Accessed 14 Feb 2022].